---

---

publishing date : 2022 - 01 - 18    crawled time : 01:00   

save search

---

Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
CRDF | $4.5 -1.96% -1.77% 830K |

Health Services

| -33.09% | O: -3.35% H: 0.0% C: 0.0%
ces pons cancer colorectal cancer

---

Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Advanced Colorectal Cancer at ASCO GI 2022
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.5M |

Health Technology

| -10.85% | O: -0.75% H: 0.0% C: 0.0%
EXEL | $22.87 0.22% 0.24% 2.3M |

Health Technology

| 27.07% | O: -1.21% H: 0.0% C: 0.0%
asco cancer colorectal cancer immunotherapy

---

Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle Conditioning
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
VERO | $0.7747 -6.66% -2.43% 56K |

Health Technology

| -57.22% | O: -0.56% H: 0.0% C: 0.0%
fda clearance cel

---

Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
RVNC | $3.76 -1.31% -1.87% 1.7M |

Health Technology

| -74.73% | O: 0.0% H: 0.0% C: 0.0%
fda xin injection submission resubmission

---

JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
GILD | $66.93 -0.57% -0.55% 3.8M |

Health Technology

| -6.93% | O: -0.65% H: 0.0% C: 0.0%
GLPG | News | $29.22 -0.92% -0.82% 180K |

Health Technology

| -47.06% | O: 1.69% H: 0.0% C: 0.0%
jyseleca treatment license ulcerative colitis

---

NexImmune to Participate in The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel on “Expanding the Possible with Next-Generation Cell Therapies”
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
NEXI | $3.15 -9.22% -11.94% 33K |

| -15.09% | O: -4.85% H: 0.0% C: 0.0%
program leukemia cel therapy

---

Notification of Cessation of Securities
Published: 2022-01-18 (Crawled : 01:00) - clinuvel.com
CLVLY | $9.75 -3.39% 31.84% 0 |

Professional, Scientific, and T...

| -46.16% | O: 0.39% H: 0.22% C: 0.22%
ces

---

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo in Certain Patients With Advanced Hepatocellular Carcinoma (HCC) Previously Treated With Sorafenib
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
MRK | $125.37 0.25% 0.44% 4.7M |

Health Technology

| 53.89% | O: -0.37% H: 0.0% C: 0.0%
keytruda cel

---

Haynes International, Inc. to Host First Quarter Fiscal Year 2022 Conference Call
Published: 2022-01-18 (Crawled : 01:00) - globenewswire.com
HAYN | $60.43 -0.17% -0.13% 460K |

Non-Energy Minerals

| 41.27% | O: -3.26% H: 0.0% C: -4.91%
conference

---

CenterPoint Energy, Inc. to Host Webcast of Fourth Quarter and Full Year 2021 Earnings Conference Call
Published: 2022-01-18 (Crawled : 01:00) - globenewswire.com
CNP | $27.7 1.76% 0.47% 4.5M |

Utilities

| -0.55% | O: 0.15% H: 1.39% C: -0.22%
conference energy

---

NSTS Bancorp, Inc. Announces Closing of Conversion and Stock Offering
Published: 2022-01-18 (Crawled : 01:00) - globenewswire.com
NSTS | $9.572 -0.19% -0.63% 1.1K |

| Email alert Add to watchlist
offering ces

---

(CORRECTION) Innovative Satellite and 5G Components Provider AmpliTech Presents Growth Strategy and Outlook in Little Grapevine Virtual Fireside Chat Thursday, Jan. 20th at 4pm ET
Published: 2022-01-18 (Crawled : 01:00) - globenewswire.com
AMPG | $2.27 0.9% -5.42% 2K |

Manufacturing

| -36.27% | O: -1.42% H: 0.57% C: -4.31%
satellite growth 5g

---

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Faraday Future Intelligent Electric, Inc. f/k/a Property Solutions Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FFIE, FFIEW, PSAC, PSACW, PSACU
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
XCUR 4 | $0.5975 -5.91% -8.55% 31K |

Commercial Services

| 245.82% | O: -0.86% H: 0.64% C: 0.12%
acquisition trial intel acquisition corp deadline

---

SHARHEOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zillow Group, Inc. of Class Action Lawsuit and Upcoming Deadline - Z; ZG
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
ZG | $41.88 -1.92% -1.93% 420K |

Technology Services

| -24.91% | O: -4.0% H: 2.0% C: -0.84%
Z | $42.54 -1.82% -1.88% 2.7M |

Technology Services

| -24.24% | O: -3.81% H: 2.59% C: 0.11%
deadline group

---

ADVENTUS MINING AND SALAZAR RESOURCES SECURE US$235.5 MILLION WITH WHEATON PRECIOUS METALS AND TRAFIGURA TO CONSTRUCT THE CURIPAMBA COPPER PROJECT
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
WPM | $52.67 2.75% 0.19% 2.8M |

Non-Energy Minerals

| 32.27% | O: -0.28% H: 1.81% C: -0.93%
als ces

---

WHEATON PRECIOUS METALS ANNOUNCES THE ACQUISITION OF A PRECIOUS METALS STREAM FROM ADVENTUS MINING'S CURIPAMBA PROJECT
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
WPM | $52.67 2.75% 0.19% 2.8M |

Non-Energy Minerals

| 32.27% | O: -0.28% H: 1.81% C: -0.93%
als acquisition ces

---

Gainers vs Losers

57%

43%

Top 10 Gainers

INVO | $1.82 139.47% 56.82% 220M |

Health Technology

SINT | $0.0373 62.88% 37.26% 460M |

Health Technology

WISA 4 | $9.25 51.64% 34.27% 64M |

Electronic Technology

EDBL | News | $6.66 46.37% 32.39% 13M |

GCTK | $0.715 36.27% 26.62% 600K |

Manufacturing

TCON | $2.29 33.92% 26.61% 1.8M |

Health Technology

TIRX | $0.4848 7.49% 24.58% 5.9M |

SRFM 4 | $0.3859 -12.3% 23.84% 660K |

n/a

KZIA | $0.3442 18.28% 23.42% 290K |

Health Technology

VNDA | News | $5.24 29.38% 22.56% 24M |

Health Technology

---

Your saved searches

---